| Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity Y He, L Fu, Y Li, W Wang, M Gong, J Zhang, X Dong, J Huang, Q Wang, ... Cell metabolism 33 (5), 988-1000. e7, 2021 | 454 | 2021 |
| Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2 Y Liu, G Hu, Y Wang, W Ren, X Zhao, F Ji, Y Zhu, F Feng, M Gong, X Ju, ... Proceedings of the National Academy of Sciences 118 (12), e2025373118, 2021 | 262 | 2021 |
| In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs L Sun, P Li, X Ju, J Rao, W Huang, L Ren, S Zhang, T Xiong, K Xu, X Zhou, ... Cell 184 (7), 1865-1883. e20, 2021 | 189 | 2021 |
| A novel cell culture system modeling the SARS-CoV-2 life cycle X Ju, Y Zhu, Y Wang, J Li, J Zhang, M Gong, W Ren, S Li, J Zhong, ... PLoS pathogens 17 (3), e1009439, 2021 | 160 | 2021 |
| Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2 S Zhang, W Huang, L Ren, X Ju, M Gong, J Rao, L Sun, P Li, Q Ding, ... Cell research 32 (1), 9-23, 2022 | 80 | 2022 |
| Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption W Ren, J Lan, X Ju, M Gong, Q Long, Z Zhu, Y Yu, J Wu, J Zhong, ... PLoS pathogens 17 (11), e1010053, 2021 | 67 | 2021 |
| Identification of functional cis-acting RNA elements in the hepatitis E virus genome required for viral replication X Ju, G Xiang, M Gong, R Yang, J Qin, Y Li, Y Nan, Y Yang, QC Zhang, ... PLoS Pathogens 16 (5), e1008488, 2020 | 31 | 2020 |
| Characterization of SARS-CoV-2 variants B. 1.617. 1 (Kappa), B. 1.617. 2 (Delta), and B. 1.618 by cell entry and immune evasion W Ren, X Ju, M Gong, J Lan, Y Yu, Q Long, DJ Kenney, AK O’Connell, ... Mbio 13 (2), e00099-22, 2022 | 24 | 2022 |
| Novel quinolone derivatives targeting human dihydroorotate dehydrogenase suppress Ebola virus infection in vitro M Gong, Y Yang, Y Huang, T Gan, Y Wu, H Gao, Q Li, J Nie, W Huang, ... Antiviral Research 194, 105161, 2021 | 12 | 2021 |
| Characterization of SARS-CoV-2 variants B. 1.617. 1 (Kappa), B. 1.617. 2 (Delta) and B. 1.618 on cell entry, host range, and sensitivity to convalescent plasma and ACE2 decoy … W Ren, X Ju, M Gong, J Lan, Y Yu, Q Long, Y Zhang, J Zhong, G Zhong, ... bioRxiv, 2021.09. 03.458829, 2021 | 9 | 2021 |
| Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry Z Zhu, Y Han, M Gong, B Sun, R Zhang, Q Ding Journal of Virology 98 (5), e01957-23, 2024 | 4 | 2024 |
| Genome-wide CRISPR/Cas9 screen identifies SLC39A9 and PIK3C3 as crucial entry factors for Ebola virus infection M Gong, C Peng, C Yang, Z Wang, H Qian, X Hu, P Zhou, C Shan, Q Ding Plos Pathogens 20 (8), e1012444, 2024 | 3 | 2024 |
| Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2 W Ren, C Fu, Y Zhang, X Ju, X Jiang, J Song, M Gong, Z Li, W Fan, J Yao, ... Proceedings of the National Academy of Sciences 121 (34), e2403235121, 2024 | 3 | 2024 |
| Modeling antiviral response in the liver using human pluripotent stem cell-derived macrophages Y Zhang, X Zhang, F Duan, H Qiao, M Gong, H Qiu, X Chen, P Wang, ... Life Medicine 3 (1), lnae001, 2024 | 1 | 2024 |
Qiang DingPrinceton University, Tsinghua UniversityPatvirtintas el. paštas tsinghua.edu.cn
